|
gptkbp:instanceOf
|
gptkb:disease
|
|
gptkbp:affects
|
adults
children
liver
|
|
gptkbp:canBeAcute
|
yes
|
|
gptkbp:canBeAsymptomatic
|
yes
|
|
gptkbp:canBeChronic
|
yes
|
|
gptkbp:canBeCured
|
yes
|
|
gptkbp:cause
|
gptkb:depression
gptkb:diabetes_mellitus
leukemia
cirrhosis
thyroid disorders
hepatocellular carcinoma
nephrotic syndrome
arthralgia
fibrosis
fatty liver
cryoglobulinemia
skin rashes
extrahepatic manifestations
|
|
gptkbp:causedBy
|
gptkb:hepatitis_C_virus
|
|
gptkbp:complication
|
gptkb:hepatic_encephalopathy
liver failure
portal hypertension
|
|
gptkbp:diagnosedBy
|
HCV RNA test
antibody test
|
|
gptkbp:firstDescribed
|
1989
|
|
gptkbp:hasVaccine
|
no
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
chronic hepatitis C
|
|
gptkbp:ICD-10_code
|
B18.2
|
|
gptkbp:managedBy
|
gastroenterologist
infectious disease specialist
|
|
gptkbp:prevalence
|
global
|
|
gptkbp:relatedTo
|
gptkb:hepatitis_A
gptkb:hepatitis_B
|
|
gptkbp:riskFactor
|
HIV infection
hemodialysis
injection drug use
|
|
gptkbp:symptom
|
nausea
abdominal pain
fatigue
jaundice
|
|
gptkbp:transmittedBy
|
blood-to-blood contact
sharing needles
blood transfusion (before 1992)
|
|
gptkbp:treatment
|
gptkb:insulin
direct-acting antivirals
ribavirin
|
|
gptkbp:bfsParent
|
gptkb:Sho-saiko-to
gptkb:INTRON_A
gptkb:PEG-INTRON
gptkb:Zepatier
gptkb:chronic_hepatitis_C_genotype_1
|
|
gptkbp:bfsLayer
|
6
|